2000.1—2002.12 Project Leader of  Natural Science Foundation (99ZB 14065) Differentiation of Benign and Malignant Thymoma and Prognostic Indicators (1)

Senior Visiting Scholar of WHO Pathological Classification of Thymic Epithelial Tumors and Lymphomas, Department of Pathology, University of Wü rzburg, Germany.

2000.10—2000.11Senior Visiting Scholar in Molecular Biology of Female Lung Cancer in Queen Mary Hospital of Hong Kong University.

2003. 1—2006. 12 Project Leader of protein Group for Non-small Cell Lung Cancer (ZD2003- 1) (the first time).

2004. 1—2005. 12 Project Leader of B3 Thymoma (0340 15) funded by Shanghai Municipal Health Bureau (first).

2004. 1—2005. 12 nano-coated particle separation and enrichment method for detecting lung cancer cells in sputum (0352nm 125)

20041—2005.12 Project Leader of Clinical Research Fund of Wu Jieping Medical Foundation (2003-2A) on Differential Diagnosis, Clinical Staging and Graded Treatment of Thymic Epithelial Tumors (First).

2007.8—2010.7 Project of Joint Development and Promotion of Appropriate Technologies in Municipal Hospitals (SHDC12007.220) Project Leader of Application of Composite Nanospheres in Early Diagnosis of Lung Cancer (1)

2007. 1—2009. 12 National Natural Science Foundation (30672394) participated in the image mass spectrometry research project of biomarkers for non-small cell lung cancer (II).

2010.1—2013.3 Project Leader, Shanghai Science and Technology Commission (10411967700)

20 10.09—20 13.09 (sub-project leader of major basic research project of Shanghai science and technology commission) mRNA and protein expression profiles of key genes in molecular typing of lung cancer and their correlation with clinical pathology (first

2010.06-2010.05 Project Leader of Magnolia Science and Technology Talent Fund of Shanghai Science and Technology Commission (20 10B098) (First)